ALXO SCHEDULE 13G: SEC filing

Coastlands Capital LP and affiliated entities

Filed with the SEC on · accession 0001104659-26-130295

ALXO filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 19, 2026. Coastlands Capital LP and affiliated entities filed a Schedule 13G disclosing beneficial ownership of 6,906,783 shares, or 5.34%, of ALX Oncology Holdings Inc. common stock as of November 12, 2026. The stock moved +5.1% by the first close after the filing.

Summary of the filing

Coastlands Capital LP and affiliated entities filed a Schedule 13G disclosing beneficial ownership of 6,906,783 shares, or 5.34%, of ALX Oncology Holdings Inc. common stock as of November 12, 2026. The filing is a passive investment disclosure under Rule 13d-1(b)/(c), with no intent to influence control of the issuer.

Key details

Shares beneficially owned$6.9M
Percent of class ownedPCT 5
Total shares outstanding$129.3M
Reporting person / investment adviserCoastlands Capital LP
Direct holder of the sharesCoastlands Capital Partners LP
General partner of coastlands capital partners lpCoastlands Capital GP LLC
General partner of coastlands capital lpCoastlands Capital LLC
IssuerALX Oncology Holdings Inc.
Control person of coastlands capital lp and affiliatesMatthew D. Perry
Chief operating officer of coastlands capital llcMark Shamia

How ALXO stock reacted

Close before

$0.97

Nov 18, 2026

First close after

+5.14%

$1.02

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ALXO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ALXO?

Click here

Frequently asked questions

What did ALXO file with the SEC on Nov 19, 2026?

ALXO filed a SCHEDULE 13G (SEC filing). Coastlands Capital LP and affiliated entities filed a Schedule 13G disclosing beneficial ownership of 6,906,783 shares, or 5.34%, of ALX Oncology Holdings Inc. common stock as of November 12, 2026. The filing is a passive investment disclosure under Rule 13d-1(b)/(c), with no intent to influence control of the issuer.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did ALXO stock react to this filing?

ALXO closed at $0.97 before the filing and $1.02 on Nov 19, 2026 (+5.14%).

Other ALXO SEC filings

Get alerts when ALXO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days